August 18, 2017 9:40 AM ET

Pharmaceuticals

Company Overview of Tacere Therapeutics, Inc.

Company Overview

Tacere Therapeutics, Inc. develops therapeutics for the treatment of infectious diseases. The company’s therapeutic compound is TT-033i, an RNA interference drug for the treatment of Hepatitis C. The company was founded in 2006 and is based in San Jose, California. As of October 30, 2012, Tacere Therapeutics, Inc. operates as a subsidiary of Benitec Biopharma Limited.

5941 Optical Court

San Jose, CA 95138

United States

Founded in 2006

Phone:

408-960-2205

Fax:

408-960-2207

Key Executives for Tacere Therapeutics, Inc.

Co-Founder, Chief Executive Officer and Director
Vice President of Research & Development
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Tacere Therapeutics, Inc., please visit www.benitec.com/about/tacere-therapeutics. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.